GlassScriptPhysician profile
Ezra J Bendit
NPI 1528145034
$2,919.63
in general payments reported to CMS, 2019-2025
29 companies · $868 in 2025
The $868 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $240 · 2021: $566 · 2022: $827 · 2023: $102 · 2024: $177 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.58 | 2021-2025 | |
| Amgen INC. | $349.58 | 2021-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $306.25 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $264.52 | 2021-2025 | Capvaxive, Gardasil 9, Verquvo |
| Astrazeneca Pharmaceuticals LP | $227.86 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Allergan, INC. | $164.54 | 2020 | |
| Boston Scientific Corporation | $153.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $146.39 | 2022-2023 | |
| Novo Nordisk INC | $122.71 | 2021-2025 | |
| Esperion Therapeutics, INC. | $75.26 | 2022-2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $65.11 | 2022-2023 | Quviviq |
| Eisai INC. | $61.13 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.57 | 2022 | |
| Almatica Pharma LLC | $54.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.78 | 2022-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $52.39 | 2022-2025 | Shingrix, Arexvy |
| Philips North America LLC | $40.73 | 2025 | Mcot |
| Baxter Healthcare | $37.41 | 2024 | Hillrom - Connex Spot Monitor |
| Lilly USA, LLC | $30.98 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $29.66 | 2025 | Inspire |
| Vistapharm, INC. | $26.28 | 2021 | |
| Exact Sciences Corporation | $23.96 | 2025 | Cologuard Collection Kit |
| Insightec,INC | $22.84 | 2025 | Exablate |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.84 | 2025 | Jardiance |
| Renalytix Ai, INC. | $21.61 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ultragenyx Pharmaceutical INC. | $21.42 | 2022 | |
| Clarus Therapeutics INC. | $19.62 | 2021 | |
| Abbott Laboratories | $16.78 | 2019 | |
| Althera Pharmaceuticals LLC | $7.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ezra Bendit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.